The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 10, 2025

Filed:

Jan. 15, 2020
Applicants:

Altor Bioscience, Llc, Miramar, FL (US);

The Usa, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Peter Rhode, Miami, FL (US);

Mark Connors, Bethesda, MD (US);

Stephen Migueles, Washington, DC (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 31/18 (2006.01); A61K 38/00 (2006.01); A61K 40/10 (2025.01); A61K 40/11 (2025.01); A61K 40/32 (2025.01); A61K 40/46 (2025.01); C07K 14/725 (2006.01);
U.S. Cl.
CPC ...
C07K 14/7051 (2013.01); A61K 40/10 (2025.01); A61K 40/11 (2025.01); A61K 40/32 (2025.01); A61K 40/46 (2025.01); A61P 31/18 (2018.01); A61K 38/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01);
Abstract

Engineered TCR molecules specific to retroviral peptide/HLA complexes guide direct killing and/or enable robust immune responses against HIV infected cells. In a first aspect, a TCR fusion polypeptide comprises a TCR variable alpha (Vα) domain, a TCR variable beta domain (Vβ) and a TCR constant region domain (C), wherein the TCR fusion polypeptide is specific for HIV peptides.


Find Patent Forward Citations

Loading…